1. Home
  2. MYNZ vs GRNQ Comparison

MYNZ vs GRNQ Comparison

Compare MYNZ & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • GRNQ
  • Stock Information
  • Founded
  • MYNZ 2021
  • GRNQ 2013
  • Country
  • MYNZ Germany
  • GRNQ Malaysia
  • Employees
  • MYNZ N/A
  • GRNQ N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • GRNQ EDP Services
  • Sector
  • MYNZ Health Care
  • GRNQ Technology
  • Exchange
  • MYNZ Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • GRNQ 7.8M
  • IPO Year
  • MYNZ 2021
  • GRNQ 2018
  • Fundamental
  • Price
  • MYNZ $0.35
  • GRNQ $1.08
  • Analyst Decision
  • MYNZ Buy
  • GRNQ
  • Analyst Count
  • MYNZ 2
  • GRNQ 0
  • Target Price
  • MYNZ $3.00
  • GRNQ N/A
  • AVG Volume (30 Days)
  • MYNZ 1.4M
  • GRNQ 620.3K
  • Earning Date
  • MYNZ 08-13-2024
  • GRNQ 08-09-2024
  • Dividend Yield
  • MYNZ N/A
  • GRNQ N/A
  • EPS Growth
  • MYNZ N/A
  • GRNQ N/A
  • EPS
  • MYNZ N/A
  • GRNQ 0.09
  • Revenue
  • MYNZ $895,479.00
  • GRNQ $3,498,328.00
  • Revenue This Year
  • MYNZ $67.40
  • GRNQ N/A
  • Revenue Next Year
  • MYNZ $191.13
  • GRNQ N/A
  • P/E Ratio
  • MYNZ N/A
  • GRNQ $12.00
  • Revenue Growth
  • MYNZ 69.00
  • GRNQ N/A
  • 52 Week Low
  • MYNZ $0.32
  • GRNQ $0.72
  • 52 Week High
  • MYNZ $4.71
  • GRNQ $1.88
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 37.39
  • GRNQ 50.28
  • Support Level
  • MYNZ $0.39
  • GRNQ $0.87
  • Resistance Level
  • MYNZ $0.46
  • GRNQ $1.65
  • Average True Range (ATR)
  • MYNZ 0.07
  • GRNQ 0.17
  • MACD
  • MYNZ 0.01
  • GRNQ 0.03
  • Stochastic Oscillator
  • MYNZ 13.88
  • GRNQ 26.51

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: